TRPV2 and breast cancer: Quantitative PCR analysis demonstrated a significant reduction in the expression levels of ATG, LC3A, and LC3B, along with an increase in SQSTM1, following TRPV2 knockdown in MCF-7, SK-BR-3, and MDA-MB-231 breast cancer cells (Figure S4A-C).